Holen Sie sich die Stockscreener-App
36.69
4.09%
1.44
Handel nachbörslich:
36.69
Schlusskurs vom Vortag:
$35.25
Offen:
$35.25
24-Stunden-Volumen:
828.63K
Relative Volume:
1.27
Marktkapitalisierung:
$2.11B
Einnahmen:
$681.88M
Nettoeinkommen (Verlust:
$122.63M
KGV:
17.39
EPS:
2.11
Netto-Cashflow:
$220.18M
1W Leistung:
+5.31%
1M Leistung:
+15.05%
6M Leistung:
-5.10%
1J Leistung:
+9.69%
1-Tages-Spanne:
$35.25
$36.74
1-Wochen-Bereich:
$34.69
$37.21
52-Wochen-Spanne:
$26.47
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Firmenname
Harmony Biosciences Holdings Inc
Sektor
Branche
Telefon
(484) 539-9800
Adresse
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Vergleichen Sie HRMY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
36.69 | 2.00B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-09-10 | Eingeleitet | UBS | Buy |
| 2024-06-21 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-25 | Herabstufung | Goldman | Neutral → Sell |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-14 | Hochstufung | Janney | Neutral → Buy |
| 2022-10-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-13 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-04 | Eingeleitet | Raymond James | Outperform |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-03-29 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-14 | Eingeleitet | Goldman | Neutral |
| 2020-09-14 | Eingeleitet | Jefferies | Buy |
| 2020-09-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
What drives Harmony Biosciences Holdings Inc. stock priceMarket-crushing profits - jammulinksnews.com
Is Harmony Biosciences Holdings Inc. a good long term investmentFree High-Return Strategy Alerts - jammulinksnews.com
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025 - Business Wire
What analysts say about Harmony Biosciences Holdings Inc. stockFree Popular Stock Recommendations - jammulinksnews.com
13 Best Low Risk High Growth Stocks to Buy - Insider Monkey
Truist Securities initiates Harmony Biosciences stock with Buy rating - Investing.com Australia
Truist Securities initiates Harmony Biosciences stock with Buy rating By Investing.com - Investing.com UK
Truist Securities Initiates Coverage on Harmony Biosciences (HRM - GuruFocus
H.C. Wainwright reiterates Buy rating on Harmony Biosciences stock - Investing.com
Truist Securities Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Truist Initiates Buy Rating for Harmony Biosciences (HRMY) with Promising Growth Prospects | HRMY Stock News - GuruFocus
Why Harmony Biosciences (HRMY) is Poised to Beat Earnings Estimates Again - MSN
Harmony Biosciences Holdings Inc. Stock Analysis and ForecastBreakout portfolio performance - jammulinksnews.com
Transcript : Harmony Biosciences Holdings, Inc. Presents at H.C. Wainwright "HCW@Home" Series, Jul-17-2025 10 - MarketScreener España
Harmony Biosciences Balances Growth Potential With Clinical Milestones - Finimize
Harmony Biosciences to Participate in H.C. Wainwright HCW@Home Series - MarketScreener
When (HRMY) Moves Investors should Listen - news.stocktradersdaily.com
Analysts Offer Insights on Healthcare Companies: Senseonics Holdings (SENS) and Harmony Biosciences Holdings (HRMY) - The Globe and Mail
Mizuho Reaffirms “Outperform” on Harmony Biosciences (HRMY) for BP1.15205 Data - MSN
Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series - BioSpace
3 Reasons Growth Investors Will Love Harmony Biosciences (HRMY) - Yahoo Finance
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now? - Yahoo Finance
Does Harmony Biosciences (HRMY) Have the Potential to Rally 43.19% as Wall Street Analysts Expect? - Zacks Investment Research
Harmony Biosciences to Participate in H.C. Wainwright "HCW@Home" Series | HRMY Stock News - GuruFocus
Harmony Biosciences CEO to Share Latest Company Updates at Exclusive H.C. Wainwright Virtual Conference - Stock Titan
Levi & Korsinsky Investigates Possible Securities Fraud Violations by Harmony Biosciences Holdings, Inc. (HRMY) - ACCESS Newswire
Most Volatile Stocks in the US (July 2025) - Investing.com
Harmony Biosciences Reaches Settlement with Lupin Over WAKIX® Patent Litigation - MSN
Harmony Biosciences Preclinical Data for Narcolepsy Drug BP1.15205 Shows Promise - MSN
Harmony Biosciences stock resumes coverage at Goldman Sachs with Neutral rating - Investing.com Canada
Goldman Sachs Resumes Harmony Biosciences Holdings Inc. (HRMY) at Neutral - StreetInsider
6 Analysts Assess Harmony Biosciences Hldgs: What You Need To Know - Benzinga
Harmony Biosciences (HRMY) Maintains Buy Rating with Price Targe - GuruFocus
Harmony Biosciences (HRMY) Maintains Buy Rating with Price Target Increase | HRMY Stock News - GuruFocus
Harmony Biosciences stock resumes coverage at Goldman Sachs with Neutral rating By Investing.com - Investing.com South Africa
H.C. Wainwright Remains Bullish on Harmony Biosciences Holdings (HRMY) - Insider Monkey
Harmony Biosciences (HRMY) Price Target Raised by Deutsche Bank Amid Key Trial | HRMY Stock News - GuruFocus
Harmony Biosciences (HRMY) Receives Neutral Rating and Price Target from Analyst | HRMY Stock News - GuruFocus
Harmony Biosciences (HRMY) Receives Neutral Rating and Price Tar - GuruFocus
Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):